Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-<i>cis</i>-Retinoic Acid

Katherine K. Matthay, Judith G. Villablanca, Robert C. Seeger et al. · New England Journal of Medicine · 1999 · 1.9K citations · Full text

Medicine, Oncology, Pharmacology +7

A BDNF autocrine loop in adult sensory neurons prevents cell death

Ann Acheson, Joanne C. Conover, James P. Fandl et al. · Nature · 1995 · 768 citations

Life Sciences, Neurobiology, Neuroscience +14

Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human Neuroblastoma

Akira Nakagawara, Miwako Arima-Nakagawara, N J Scavarda et al. · New England Journal of Medicine · 1993 · 690 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

B. Douglas Smith, Mark J. Levis, Miloslav Beran et al. · Blood · 2004 · 629 citations

Medicine, Oncology, Pharmacology +11